Pixium Vision - US feasibility study now underway

On 13 January Pixium Vision announced the first implantation of the Prima system in the US, as part of its US feasibility trial in five patients with advanced dry age-related macular degeneration with geographic atrophy. The procedure was the first to use Pixium’s new proprietary delivery system, designed to greatly improve the ease of implantation and result in a safer and less invasive procedure. The procedure was performed at the University of Pittsburgh Medical Center; more implantations are expected throughout the year at this site and at Bascom Palmer Eye Institute.